Clients in the News: RWJBH, Stanford, Swedish and more

RWJBarnabas Health embraces antibody therapy for high-risk COVID-19 patients, Stanford Health Care performs a record number of heart transplants, and Swedish Health Services appoints its first chief health equity officer—all this and more in this month’s Clients in the News.

How RWJBarnabas Health is administering monoclonal antibodies

RWJBarnabas Health has moved forward quickly in treating COVID-19 patients with monoclonal antibody therapy, giving the medication to patients within 10 days of emergency use authorization at all 11 of the health system’s hospitals. Out of the 3,200 patients who had received the therapy as of February 11, more than 95% did not require hospitalization. (Health Leaders Media)

Amid COVID-19, Stanford surgeons perform record number of heart transplants

While the COVID-19 pandemic forced some transplant centers to close, it was a busy year for Stanford Health Care, where surgeons performed a record 86 heart transplants in 2020. (Becker’s Hospital Review)

Swedish Health Services names inaugural chief health equity officer

Nwando Anyaoku, MD, has been chosen as the first chief health equity officer of Seattle-based Swedish Health Services. He will direct programs to measure equity in medical care and outcomes, improve patient access, and promote culturally competent care, according to a March 3 news release. (Becker’s Hospital Review)

AI model IDs high-risk cardiovascular patients based on imaging data

Researchers have developed a new AI algorithm that uses imaging results to identify patients at a heightened risk of a major adverse cardiovascular event (MACE), publishing their findings in Nature Communications. The team behind the study included specialists from Brigham and Women’s Hospital, Harvard Medical School, Massachusetts General Hospital (MGH), Boston University and Duke University. (Cardiovascular Business)

UCSF says the root of some health disparities may be buried in technology

As the coronavirus pandemic revealed significant disparities in health equity, executives at the University of California San Francisco turned to an interesting place to address this issue: technology. And what they discovered was fascinating. Bias built into algorithms, predictive models, and processes could be the root of some problems. (Health Leaders Media)

Posted by Jana Ballinger 03/11/2021 Categories: Clients in the News COVID-19